Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution.
Cost of Illness of Multiple Sclerosis - A Systematic Review.
Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells.
The liminal self in people with multiple sclerosis: An interpretative phenomenological exploration of being diagnosed.
Long-term poor rapport, lack of spontaneity and passive social withdrawal related to acute post-infectious encephalitis: a case report.
PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption.
Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis.
Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterations.
Paediatric brainstem: A comprehensive review of pathologies on MR imaging.
[Cannabis: Effects in the Central Nervous System. Therapeutic, societal and legal consequences].
Considerations in the development of generic disease therapies for multiple sclerosis.
Nogo-A does not inhibit retinal axon regeneration in the lizard, Gallotia galloti.
"Gait responder" to fampridine, a too restrictive concept?
Neuroimaging findings of Zika virus infection: a review article.
SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review.
Lysophosphatidic acid provides a missing link between osteoarthritis and joint neuropathic pain.
Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.
A qualitative study of patient and professional perspectives of healthcare services for multiple sclerosis: implications for service development and policy.
Overview and diagnosis of multiple sclerosis.
Sensory gating of auditory evoked potentials in rats: effects of repetitive stimulation and the interstimulus interval.
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
The importance of a multi-disciplinary perspective and patient activation programmes in MS management.
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
Pathoetiology of multiple sclerosis: are we barking up the wrong tree?
Pages
« first
‹ previous
…
743
744
745
746
747
748
749
750
751
…
next ›
last »